Fingerprint
Dive into the research topics of 'Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
Mansoor Husain, Stephen C. Bain, Ole K. Jeppesen, Ildiko Lingvay, Rasmus Sørrig, Marianne B. Treppendahl, Tina Vilsbøll
Research output: Contribution to journal › Article › peer-review
101
Scopus
citations